INMB Stock Analysis: Buy, Sell, or Hold?

INMB - INmune Bio Inc. Common stock

BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
$1.49
-0.06 (-3.87%) ▼
5d: +10.37%
30d: +2.76%
90d: +6.43%
HOLD
MODERATE Confidence
Analysis Updated: May 18, 2026 12:00 AM ET
Earnings: May 07, 2026 0d

Get Alerted When INMB Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: INMB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: INMB is currently trading at $1.49, which is considered extended relative to its 30-day fair value range of $1.29 to $1.51.

Technical Outlook: Technically, INMB is in a strong downtrend. Immediate support is located at $1.31, while resistance sits at $1.79. Short-term momentum is weak, with the stock down 3.9% recently.

Market Sentiment: INMB has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $7.00 (+369.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $1.29 - $1.51
Company Quality Score 58/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 57.9%

All Signals

  • BEARISH: Price extended above range
  • BULLISH: Strong technical setup (75/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-3.9%)
  • BULLISH: Trading 369.8% below Wall St target ($7.00)

Trading Range Analysis

30-Day Trading Range $1.29 - $1.51
Current vs Trading Range EXTENDED

Support & Resistance Levels

Support Level $1.31
Resistance Level $1.79
Current Trend Strong Downtrend
Technical data as of May 18, 2026

Fundamental Context

Forward P/E (Next Year Est.) -2.84
Wall Street Target $7.00 (+369.8%)
Revenue Growth (YoY) 257.1%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: May 18, 2026 10:55 PM ET
Data refreshes hourly during market hours. Next update: 11:55 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for INMB.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ACLX
Arcellx Inc
STRONG BUY
18 analysts
$113 57 HOLD
BNTX
BioNTech SE
STRONG BUY
21 analysts
$126 55 HOLD
INCY
Incyte Corporation
HOLD
27 analysts
$109 58 HOLD
MLTX
MoonLake Immunotherapeut…
STRONG BUY
16 analysts
$28 52 HOLD
BBIO
BridgeBio Pharma Inc
STRONG BUY
19 analysts
$103 53 HOLD

More Analysis for INMB

INMB Technical Chart INMB Price Prediction INMB Earnings Date INMB Investment Advisor INMB Fair Price Analyzer INMB Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals